DOCSLIB.ORG

Appendix C Wound Dressings for Surgical Site Infection Prevention

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Appendix C Wound Dressings for Surgical Site Infection Prevention Surgical site infection Surgical site infection National Collaborating Centre for Women’s and Children’s Health Other NICE guidelines produced by the National Collaborating Centre for Women’s and Children’s Health include: • Antenatal care: routine care for the healthy pregnant woman • Fertility: assessment and treatment for people with fertility problems • Caesarean section • Type 1 diabetes: diagnosis and management of type 1 diabetes in children and young people • Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception • Urinary incontinence: the management of urinary incontinence in women • Heavy menstrual bleeding • Feverish illness in children: assessment and initial management in children younger than 5 years • Urinary tract infection in children: diagnosis, treatment and long-term management • Intrapartum care: care of healthy women and their babies during childbirth • Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years • Surgical management of otitis media with effusion in children • Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period Surgical site infection • Induction of labour Guidelines in production include: prevention and treatment of • Diarrhoea and vomiting in children under 5 prevention and treatment of • When to suspect child maltreatment • Hypertensive disorders in pregnancy • Neonatal jaundice surgical site infection • Constipation in children • Bacterial meningitis and meningococcal septicaemia in children • Pregnant women with complex social factors • Autism in children and adolescents • Multiple pregnancy Enquiries regarding the above guidelines can be addressed to: National Collaborating Centre for Women’s and Children’s Health King’s Court Fourth Floor 2–16 Goodge Street London W1T 2QA [email protected] Clinical A version of this guideline for patients, carers and the public is available from the NICE website (www.nice.org.uk/CG074) or from NICE publications on 0845 003 7783; quote reference number N1702. Guideline October 2008 Published by the Royal College of Obstetricians and Gynaecologists. Clinical Guideline To purchase further copies and for a complete list of RCOG Press titles, RCOG October 2008 RCOG Press Press visit: www.rcogbookshop.com 2008 Funded to produce guidelines for the NHS by NICE Surgical site infection prevention and treatment of surgical site infection National Collaborating Centre for Women’s and Children’s Health Commissioned by the National Institute for Health and Clinical Excellence October 2008 RCOG Press Published by the RCOG Press at the Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent’s Park, London NW1 4RG www.rcog.org.uk Registered charity no. 213280 First published 2008 © 2008 National Collaborating Centre for Women’s and Children’s Health No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use. While every effort has been made to ensure the accuracy of the information contained within this publication, the publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check current indications and accuracy by consulting other pharmaceutical literature and following the guidelines laid down by the manufacturers of specific products and the relevant authorities in the country in which they are practising. ISBN 978-1-904752-69-1 NCC-WCH Editor: Andrew Welsh Original design: FiSH Books, London Typesetting: Andrew Welsh Proofreading: Katharine Timberlake (Reedmace Publishing Ltd) Index: Jan Ross (Merrall-Ross (Wales) Ltd) Printed by Henry Ling Ltd, The Dorset Press, Dorchester DT1 1HD Contents Guideline Development Group membership and acknowledgements v Guideline Development Group v Acknowledgements v Stakeholder organisations vi Abbreviations xi Glossary of terms xii 1 Introduction 1 1.1 Surgical site infection 1 1.2 Aim of the guideline 3 1.3 Areas outside of the remit of the guideline 3 1.4 For whom is the guideline intended? 3 1.5 Who has developed the guideline? 3 1.6 Other relevant documents 4 1.7 Guideline methodology 4 1.8 Schedule for updating the guideline 7 2 Summary of recommendations 8 2.1 Key priorities for implementation (key recommendations) 8 2.2 Summary of recommendations 9 2.3 Key priorities for research 12 2.4 Summary of research recommendations 13 3 Definitions, surveillance and risk factors 15 3.1 Defining surgical site infection 15 3.2 Surveillance for surgical site infection 15 3.3 Risk factors 16 4 Information for patients and carers 21 4.1 Information for patients and carers 21 5 Preoperative phase 23 5.1 Preoperative showering 23 5.2 Hair removal 25 5.3 Patient theatre wear 28 5.4 Staff theatre wear 29 5.5 Staff leaving the operating area 30 5.6 Nasal decontamination 30 5.7 Mechanical bowel preparation 33 5.8 Hand decontamination (general) 35 5.9 Hand jewellery, artificial nails and nail polish 35 5.10 Antibiotic prophylaxis 36 6 Intraoperative phase 50 6.1 Hand decontamination 50 6.2 Incise drapes 51 6.3 Use of sterile gowns 53 6.4 Disposable or reusable drapes and gowns 54 6.5 Gloves 55 6.6 Antiseptic skin preparation 56 6.7 Diathermy 60 6.8 Maintaining patient homeostasis 62 6.9 Wound irrigation and intracavity lavage 66 6.10 Antiseptic and antimicrobial agents before wound closure 73 6.11 Closure methods 76 6.12 Wound dressings 86 iii Surgical site infection 7 Postoperative phase 91 7.1 Changing dressings 91 7.2 Postoperative cleansing 92 7.3 Topical antimicrobial agents for wound healing by primary intention 93 7.4 Dressings for wound healing by secondary intention 94 7.5 Antibiotic treatment of surgical site infection and treatment failure 97 7.6 Debridement 98 7.7 Specialist wound care services 99 Appendix A Declarations of interest 100 Appendix B Clinical questions 101 Appendix C Wound dressings for surgical site infection prevention 103 Appendix D Cost-effectiveness of hair removal 105 Appendix E Cost-effectiveness of mupirocin nasal ointment to prevent surgical site infection 110 caused by Staphylococcus aureus Appendix F Cost-effectiveness of closure methods 117 Appendix G Cost analysis of wound dressings 119 Appendix H General principles for hand hygiene (epic2) 122 Appendix I Postoperative cleansing of the wound 124 References 125 Index 133 Search strategies CD-ROM Excluded studies CD-ROM Evidence tables CD-ROM iv Guideline Development Group membership and acknowledgements Guideline Development Group GDG members Mark Collier Lead Nurse/Consultant – Tissue Viability David Evans Patient/carer member (Safety Engineer and Occupational Hygienist) Mark Farrington Consultant Medical Microbiologist Elizabeth Gibbs Patient/carer member (Teenage Pregnancy Specialist Midwife) Kate Gould Consultant Microbiologist (Clinical Advisor to the GDG) Helen Jenkinson Hygiene Code Implementation Manager Kathryn Kitson Team Leader for Orthopaedic and Trauma Theatres (stood down in December 2007 owing to work commitments) David Leaper GDG Chair, Visiting Professor, Department of Wound Healing Matt Thompson Professor of Vascular Surgery Jennie Wilson Infection Control Nurse/Programme Leader, Surgical Site Infection Surveillance Service National Collaborating Centre for Women’s and Children’s Health (NCC-WCH) staff Shona Burman-Roy Systematic Reviewer Katherine Cullen Health Economist Eva Gautam-Aitken Project Manager Paul Jacklin Senior Health Economist Ana Palanca Research Assistant Edmund Peston Document Supply Coordinator Roxana Rehman Work Programme Coordinator Andrew Welsh Freelance copy-editor and typesetter Martin Whittle Clinical Co-Director Danielle Worster Information Scientist External advisers John Black Consultant Surgeon Alice Jones Senior Sister in General and Emergency Surgery Grainne Nicholson Consultant Anaesthetist Acknowledgements Additional support was received from: • Anna Bancsi, Martin Dougherty, Debbie Pledge, Roz Ullman and Angela Kraut at the NCC-WCH • Caroline Keir at the National Institute for Health and Clinical Excellence (NICE) • The Patient and Public Involvement Programme (PPIP) for NICE • Judith Tanner, Nancy Dryburgh, Joan Webster and Sally Bell-Syers of the Cochrane Wounds Group • Dr Roberta Jenkins at the Scottish Intercollegiate Guidelines Network (SIGN) • Dr Rosa Legood, Health Economist, London School of Hygiene & Tropical Medicine v Surgical site infection This guideline was developed from work initially undertaken by the National Collaborating Centre for Nursing and Supportive Care (NCC-NSC) and the members of the 2005 GDG, as part of an earlier NICE commission (http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11622). GDG members (2005 consultation version) Una Adderley Tissue Viability Prescribing Specialist Nurse Mark Collier Lead Nurse/Consultant – Tissue Viability Christopher Dowson Professor of Microbiology
Load more

Recommended publications
  • British Journal of Urology International
    BJU International Official journal of the British Association of Urological Surgeons and the Urological Society of Australasia August 2005 - Vol. 96 Issue 3 Page i-469 i Editor's comment Online publication date: 24-Jul-2005 Comments 231 How should we advise patients about the chemoprevention of prostate cancer? Roger S. Kirby, John M. Fitzpatrick Online publication date: 24-Jul-2005 232 A proposal for a new classification for operative procedures for stress urinary incontinence Paul Abrams, Paul Hilton, Malcolm Lucas, Tony Smith Online publication date: 24-Jul-2005 233 Renal transplantation and manpower issues Dler Besarani, David Cranston Online publication date: 24-Jul-2005 234 Is premature ejaculation all in the mind? John Dean, Ian Eardley, Geoff Hackett, Jeremy Heaton, Roger Kirby Online publication date: 24-Jul-2005 Mini-reviews 237 Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia Ajay Nehra Online publication date: 24-Jul-2005 244 Robotic renal and adrenal surgery: present and future Rajeev Kumar, Ashok K. Hemal, Mani Menon Online publication date: 24-Jul-2005 250 Targeting bladder outlet obstruction from benign prostatic enlargement via the nitric oxide/cGMP pathway? André Reitz, Michael Müntener, Axel Haferkamp, Markus Hohenfellner, Brigitte Schurch Online publication date: 24-Jul-2005 254 The vital role of creativity in academic departments Jeremy P.W. Heaton Online publication date: 24-Jul-2005 Great Drug Classes 257 Phosphodiesterase type 5 inhibitors for erectile dysfunction Culley C. Carson, Tom F. Lue Online publication date: 24-Jul-2005 Urological Oncology 281 Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma John T.
    [Show full text]
  • Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017
    Supplementary Online Content Berríos-Torres SI, Umscheid CA, Bratzler DW, et al; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. Published online May 3, 2017. doi:10.1001/jamasurg.2017.0904 eAppendix 1. Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection 2017 –Background, Methods and Evidence Summaries eAppendix 2. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017: Supplemental Tables This supplementary material has been provided by the authors to give readers additional information about their work. © 2017 American Medical Association. All rights reserved. 1 Downloaded From: https://jamanetwork.com/ on 09/30/2021 eAppendix 1. Centers for Disease Control and Prevention, Guideline for the Prevention of Surgical Site Infection 2017: Background, Methods and Evidence Summaries TABLE OF CONTENTS 1. BACKGROUND ........................................................................................................................................................................................................................................................... 4 1.1. Prosthetic Joint Arthroplasty ................................................................................................................................................................................................................................
    [Show full text]
  • The Canadian Medical Review
    v^I:J.l^aLiJaT^ rAmrca^ Rexyiew m vol r^^^^^^ INDEX, 1895. 528626 VOL. I. It. 10.51 ORIGINAL COMMUNICATIONS. PAGE Recent Electro Theiapeusis of Goitre, with Improvements in Apparatus. By Dr. C. R. Dickson, Toronto i Treatment of Colles' Fracture. By Dr. William Britton, Toronto 5 Tumor of the Middle Lobe of the Cerebellum. By D. C. Meyers, M.D., Toronto 35 Two Cases of Tubal Gestation. By A. B. Atherton, M.D., Toronto * 38 The Care of the Eyes in Newspaper Work. By Dr. G. S. Ryerson, Toronto 75 Regarding the Eruption in a Case of Variola, in which Vac- cinia Ran Concurrently ; with Remarks on the Pathology. By Dr. J. N. E. Brown, Toronto 77 The Treatment of Dysmenorrhoea. By Albert A. Macdonald, M.D 119 The Treatment of Diseases of the Fallopian Tubes. By Dr. A. Lapthorn Smith 159 The Treatment of Diseases of the Fallopian Tubes and Ovaries. By A. Lapthorn Smith, B.A., M. D., Montreal 199 Notes on the Medical Service. By Dr. G. Sterling Ryerson . 208 CLINICAL NOTES. A Case of Infantile Spinal Paralysis. By Dr. W. W. Bremner, Toronto 8 A Peculiar Fracture of the Clavicle. By Dr. J. J. Cassidy, Toronto 10 A Case of Malingering. By Murray McFarlane, M.D., Toronto 41 Short Notes on Three Cases of Poisoning. By Dr. B. Spencer, Toronto 82 Hysteria in a Child. By Dr. D. C Meyers, Toronto 83 Notes on a Case of Arrested Tuberculosis. By Dr. Garratt, Toronto 85 A Peculiar Case of Diphtheria. By Dr. J. T. Fotheringham, Toronto 86 Foreign Body in CEsophagus.
    [Show full text]
  • Oesophageal Foreign Bodies - from Diagnostic Challenge to Therapeutic Dilemma
    General Report Chirurgia (2016) 111: 102-114 No. 2, March - April Copyright© Celsius Oesophageal Foreign Bodies - from Diagnostic Challenge to Therapeutic Dilemma Dragoæ Predescu1, Irina Predescu2, Codruå Sarafoleanu2, Silviu Constantinoiu1 1Esophageal and General Surgery Clinic, St. Mary Hospital, Carol Davila University of Medicine and Pharmacy Bucharest, Romania 2ENT Department, St. Mary Hospital, Carol Davila University of Medicine and Pharmacy Bucharest, Romania Rezumat Manifestãrile de alertã, care indicã apariåia complicaåiilor sunt: stare febrilã, alterarea stãrii generale, durere (proiecåie verebralã Corpii strãini esofagieni - de la provocare diagnosticã la /interscapularã), împãstare, emfizem cervical subcutanat. dilemã terapeuticã Diagnosticul imagistic prin variantele sale (Rx simplã, tranzit Ingestia de corpi strãini, frecvent întâlnitã în serviciile de baritat, CT, RMN) rãmâne veriga esenåialã în identificarea urgenåã, rãmâne o provocare pentru medici în ciuda mãsurilor lezionalã æi decizia terapeuticã. Evaluarea endoscopicã (rigidã preventive æi a progreselor tehnice datoritã frecvenåei æi sau flexibilã) este obligatorie, permiåând æi gesturi terapeutice. complicaåiilor posibile, complicaåii grave ce pot întuneca Evolutiv (80-90%) FB migreazã în stomac fiind eliminaåi pe cãi prognosticul vital sau pot fi sursã de morbiditate la distanåã. naturale, la cca 10-20% este necesarã extracåie pe cale endos- Experienåa clinicii ”Sf. Maria” raporteazã în intervalul 2000- copicã æi doar la 1% din cazuri se impune un gest chirurgical. 2015, 39 de pacienåi diagnosticaåi cu ingestie de FB, din care Tratamentul cazurilor necomplicate este esenåial endoscopic 26 fixaåi la nivelul esofagului iar restul de 13 au trecut în aval fie, de excepåie, intervenåie chirurgicalã pentru extragerea spontan (5 recuperaåi din stomac, 6 evacuaåi natural, 2 cazuri cu corpului strãin. În faåa complicaåiilor, chirurgia este singura perforaåie colicã).
    [Show full text]
  • Clinical Presentation and Diagnosis of Acute Postoperative Spinal Implant Infection (PSII)
    771 Review Article on Postoperative Spinal Implant Infection Clinical presentation and diagnosis of acute postoperative spinal implant infection (PSII) Timo Zippelius1, Justus Bürger2, Friederike Schömig2, Michael Putzier2, Georg Matziolis1, Patrick Strube1 1Orthopaedic Professorship of the University Hospital Jena, Orthopaedic Department of the Waldkliniken Eisenberg, Eisenberg, Germany; 2Center for Musculoskeletal Surgery, Charité University Medicine Berlin, Berlin, Germany Contributions: (I) Conception and design: T Zippelius, G Matziolis, P Strube; (II) Administrative support: G Matziolis, J Bürger; (III) Provision of study material or patients: None; (IV) Collection and assembly of data: F Schömig, J Bürger; (V) Data analysis and interpretation: F Schömig, J Bürger; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Dr. med. Timo Zippelius. Orthopaedic Department of the Waldkliniken Eisenberg, Orthopaedic Professorship of the University Hospital Jena, Klosterlausnitzer Str. 81, 07607 Eisenberg, Germany. Email: [email protected]. Abstract: Acute postoperative infections after surgical interventions on the spinal column are associated with prolonged treatment duration, poor patient outcomes, and a high socioeconomic burden. In the field of joint replacement, guidelines have been established with recommendations for the diagnosis and treatment of such complications, but in spinal surgery there are no definitions permitting distinction between early and late infections and no specific instructions for their management. Various factors increase the risk of acute postoperative infection, including blood transfusions, leakage of cerebrospinal fluid, urinary tract infection, injury of the dura mater, an American Society of Anesthesiologists (ASA) score >2, obesity, diabetes mellitus, and surgical revision. We suggest defining all infections occurring within the first 4 weeks after spinal surgery as early infections.
    [Show full text]
  • Phh 1333 01 Vivano
    02/2016 Vivano® Spectrum Convincing case examples of negative-pressure wound therapy. Abdominal · Traumatic · Chronic · Special Indication Editorial details Published by PAUL HARTMANN AG, P. O. Box 1420, 89504 Heidenheim, Telephone: +49 7321 36 – 0, www.hartmann.info Issue: 02/2016 Photographs: Martin Huťan (p. 7), Cristian Velicescu (p. 9), Adam Bobkiewicz (p. 11), Jiří Voves (p. 13), Zs Szentkereszty (p. 15), Astrid Schielke (p. 17), Wim Fleischmann (p. 19), Miroslav Budoš (p. 21), Susanu Sidonia (p. 23), Csaba Tóth (p.25), Sándor Pellek (p. 27), Stefan Georgescu (p. 29), Natália Santos (p. 31), Thorsten Vowinkel (p. 33), Darko Jurišić (p. 35), Martin Bohac (p. 37), Tomasz Tuzikiewicz (p. 39), Michal Konrád (p. 41), Marco Fraccalvieri (p. 43), Berthold Johann Vogel (p. 45), Title: © Formzwei, Stuttgart Copyright: PAUL HARTMANN AG reserves all rights, such as reprints, also of images, reproductions of any kind, talks, radio, audio and television broadcasts as well as the storage in data processing systems, including excerpts or translations. The cases in this journal are shown as they have been seen in clinical practice and independently conducted by the responsible health care professionals within their freedom of treatment and in certain cases using the products off-label. They have not been edited by PAUL HARTMANN AG and do not represent clinical recommendations of PAUL HARTMANN AG. The only officially approved use of the products from the VIVANO range recommended by PAUL HARTMANN AG can be found in the respective instructions for use. Editorial Dear Colleagues, I am very pleased to introduce the sixth edition of the “Vivano Spectrum” series.
    [Show full text]
  • Necrotising Enterocolitis in Preterm Infants With
    JURNALUL PEDIATRULUI – Year XVII, Vol. XVII, Nr. 65-66, january-junre 2014 EDITOR IN CHIEF Eugen Sorin BOIA CO-EDITORS Radu Emil IACOB Liviu POP Maria TRAILESCU SECRETARY Radu Emil IACOB Vlad Laurentiu DAVID EDITORIAL BOARD O Adam Valerica Belengeanu Marioara Boia A Craciun M Gafencu Daniela Iacob A Pirvan CM Popoiu Maria Puiu R Spataru I Velea EDITORIAL CONSULTANTS M Ardelean – Salzburg, Austria Valerica Belengeanu – Timisoara, Romania Jana Bernic – Chisinau, Moldavia ES Boia – Timisoara, Romania Maria Bortun – Timisoara, Romania V Fluture – Timisoara, Romania S Garofallo – Milano, Italy DG Gotia – Iasi, Romania ADDRESS C Ilie – Timisoara, Romania Tamás Kovács – Szeged, Hungary Timisoara, Romania Silvo Lipovšek– Maribor, Slovenia Gospodarilor Street, nr. 42 E Lazăr – Timisoara, Romania Tel: +4-0256-439441 J Mayr – Basel, Switzerland cod 300778 Eva Nemes – Craiova, Romania e-mail: [email protected] Gloria Pelizzo – Pavia, Italy L Pop – Timisoara, Romania JURNALUL PEDIATRULUI – Year XVII, I Popa – Timisoara, Romania Maria Puiu – Timisoara, Romania Vol. XVII, Nr. 65-66, january-june 2014 GC Rogers – Greenville, USA www.jurnalulpediatrului.ro J Schalamon – Graz, Austria ISSN 2065 – 4855 I Simedrea – Timisoara, Romania Rodica Stackievicz – Kfar Sava, Israel REVISTA SOCIETĂŢII ROMÂNE H Stackievicz – Hadera, Israel DE CHIRURGIE PEDIATRICĂ Penka Stefanova - Plvdiv, Bulgaria www.srcp.ro C Tica – Constanta, Romania 1 JURNALUL PEDIATRULUI – Year XVII, Vol. XVII, Nr. 65-66, january-junre 2014 CONTENTS 1. A SEVEN YEARS EXPERIENCE IN HIRSCHSPRUNG’S DISEASE TREATMENT Radu-Iulian Spataru, Niculina Bratu, Monica Ivanov, Dan-Alexandru Iozsa………………………………………………3 2. DAILY PRACTICE OF MECHANICAL VENTILATION IN A PEDIATRIC INTENSIVE CARE UNIT - EXPERIENCE OF THE FIRST PEDIATRIC CLINIC TIMISOARA Daniela Chiru, Craciun A, Tepeneu NF, David VL, Otilia Marginean, Ilie C.…………………………………….....…….6 3.
    [Show full text]
  • Infections of the Musculoskeletal System”
    Infections of the musculoskeletal system Basic principles, prevention, diagnosis and treatment Published by the swiss orthopaedics and the Swiss Society for Infectious Diseases expert group “Infections of the musculoskeletal system” 1st electronic edition in English 2016 Peter E. Ochsner, Olivier Borens, Paul-Michael Bodler, Ivan Broger, Gerhard Eich, Fritz Hefti, Thomas Maurer, Hubert Nötzli, Stefan Seiler, Domizio Suvà, Andrej Trampuz, Ilker Uçkay, Markus Vogt, Werner Zimmerli Infections of the musculoskeletal system Basic principles, prevention, diagnosis and treatment 1st electronic edition in English 2016 Published by swiss orthopaedics and the Swiss Society for Infectious Diseases expert group “Infections of the musculoskeletal system” Cover illustrations: Femoral head prosthesis with delayed infection, resulting in cartilage wear, acetabular roof cysts and loosening of cement and prosthesis. Detail: Implant surface with established biofilm (scanning electron microscope). 1st German edition 2013, reprint 2014 2nd German edition 2015, reprint 2016 1st English edition 2014 1st French edition 2015 1st Chinese edition 2015 Important information about using this text: The reader can rest assured that the expert group, the authors, the editor and the publisher have taken great care when referring to dosages or recommended appli- cations within these guidelines to ensure that they conform to the state of the art. However, each user is advised to discuss medication dosages with qualified specialists and to verify them by carefully studying the corresponding package insert prior to initiating treatment. Any updates to treatment plans must also be taken into consideration. The expert group would like to encourage all users to report any inaccuracies. The contents of these guidelines are copyright protected.
    [Show full text]
  • Archive of Clinical Cases
    www.clinicalcases.eu Archive of Clinical Cases Subpectoral pacemaker implant after repeated pocket complications due to “senile pruritus” Andreea-Maria Ursaru1, Andreea-Mihaela Ignat*,1, Dana Corduneanu2, Gabriel Mazilu3, Antoniu Octavian Petriș1,4, Dan-Nicolae Tesloianu1 1Cardiology Department, “Sf. Spiridon” University Emergency Hospital, Iasi, Romania, 2Internal Medicine Department, “Sf. Spiridon” University Emergency Hospital, Iasi, Romania, 3Plastic and Reconstructive Microsurgery Department, “Sf. Spiridon” University Emergency Hospital, Iasi, Romania, 4“Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania Abstract Complications that can occur after pacemaker implant may be surgical or programming function related. We report a case of an 89-years old patient with slow atrial fibrillation, initially treated by external temporary pacing, and then by permanent pacemaker implant. The clinical course in the first months after procedure was uneventful, but after a half-year from the first admission, the patient addressed for pacemaker pocket infection, complaining of intense pruritus. After the drainage of the purulent secretions, the patient developed pocket hematoma, despite of Velpeau bandages and antipruritic drugs. Being a non-compliant patient with high risk of reinfection, it was decided, four days later after hematoma evacuation, to relocate the device on the same side, beneath pectoralis major muscle. This case presents two of the device pocket surgical complications (infection and hematoma) that occurred long after the implantation procedure due to senile pruritus. Keywords: pacemaker pocket infection, permanent pacemaker, senile pruritus, pocket hematoma, subpectoral pacemaker implant Introduction palpability, or exposure, plastic surgeons may be consulted for reimplanting the device using Originally implanted in the anterior a subpectoral approach [4].
    [Show full text]
  • Surgical Site Infection
    DRAFT FOR CONSULTATION Surgical site infection National Collaborating Centre for Women’s and Children’s Health Commissioned by the National Institute for Health and Clinical Excellence DRAFT FOR CONSULTATION April 2008 RCOG Press Surgical site infection: full guideline DRAFT (April 2008) page i of 165 DRAFT FOR CONSULTATION Contents Guideline Development Group membership and acknowledgements iv Guideline Development Group iv Acknowledgements iv Stakeholder organisations v Abbreviations ix Glossary of terms xi 1 Introduction 1 1.1 Surgical site infection 1 1.2 Aim of the guideline 4 1.3 Areas outside of the remit of the guideline 4 1.4 For whom is the guideline intended? 4 1.5 Who has developed the guideline? 5 1.6 Other relevant documents 5 1.7 Guideline methodology 5 1.8 Schedule for updating the guideline 9 2 Summary of recommendations and care pathway 10 2.1 Key priorities for implementation (key recommendations) 10 2.2 Summary of recommendations 11 2.3 Key priorities for research 14 2.4 Summary of research recommendations 15 2.5 Care pathway 16 3 Risk Factors 18 4 Information for patients 19 5 Preoperative phase 21 5.1 Preoperative showering 21 5.2 Hair removal 23 5.3 Patient theatre attire 26 5.4 Non-sterile theatre wear 26 5.5 Staff leaving the operating area in non-sterile theatre wear 27 5.6 Nasal decontamination 28 5.7 Mechanical bowel preparation 30 5.8 Hand decontamination (general) 32 5.9 Hand jewellery, artificial nails and nail polish 32 5.10 Antibiotic prophylaxis 33 6 Intraoperative phase 46 6.1 Hand decontamination (scrubbing)
    [Show full text]
  • Surgical Site Infection Surgical Site Infection National Collaborating Centre for Women’S and Children’S Health
    Surgical site infection Surgical site infection National Collaborating Centre for Women’s and Children’s Health Other NICE guidelines produced by the National Collaborating Centre for Women’s and Children’s Health include: • Antenatal care: routine care for the healthy pregnant woman • Fertility: assessment and treatment for people with fertility problems • Caesarean section • Type 1 diabetes: diagnosis and management of type 1 diabetes in children and young people • Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception • Urinary incontinence: the management of urinary incontinence in women • Heavy menstrual bleeding • Feverish illness in children: assessment and initial management in children younger than 5 years • Urinary tract infection in children: diagnosis, treatment and long-term management • Intrapartum care: care of healthy women and their babies during childbirth • Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years • Surgical management of otitis media with effusion in children • Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period Surgical site infection • Induction of labour Guidelines in production include: prevention and treatment of • Diarrhoea and vomiting in children under 5 prevention and treatment of • When to suspect child maltreatment • Hypertensive disorders in pregnancy • Neonatal jaundice surgical site infection • Constipation in children • Bacterial
    [Show full text]
  • Prevention of Surgical Site Infections
    Prevention of Surgical Site Infections Sinil Nair, CIC Infection Control Expert Clinical Quality and Healthcare Accreditation Department, MOHAP Background a) The second most common (20%) of all HAIs in hospitalized patients. b) Occurs in 2%–5% of patients undergoing inpatient surgery. c) One of the most preventable HAIs. a) Up to 60% of SSIs are preventable by using evidence-based guidelines. d) Each SSI is associated with ≈ 7–11 additional hospital-days. Background e) 3% Mortality f) Patients with an SSI have a 2–11-times higher risk of death compared with operative patients without an SSI. g) 77% of deaths in patients with SSI are directly attributable to SSI. h) The most costly HAI i) Long term disabilities Types of SSI NHSN Definitions 1. Superficial incisional SSI Must meet the following criteria: a) Infection occurs within 30 days after any operative procedure (where day 1 = the procedure date) AND a) involves only skin and subcutaneous tissue of the incision AND c) patient has at least one of the following: i. purulent drainage from the superficial incision. ii. organisms identified from an aseptically-obtained specimen from the superficial incision or subcutaneous tissue by a culture or non-culture based microbiologic testing method which is performed for purposes of clinical diagnosis or treatment (e.g., not Active Surveillance Culture). iii. superficial incision that is deliberately opened by a surgeon, attending physician or other designee and culture or non-culture based testing is not performed. AND patient has at least one of the following signs or symptoms: pain or tenderness; localized swelling; erythema; or heat.
    [Show full text]